Nanthealth Stock Valuation

NH
 Stock
  

USD 0.61  0.04  7.02%   

Do you want to know what the current value of Nanthealth is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Nanthealth, is its stock price multiplied by the total number of shares outstanding, calculating Nanthealth's enterprise value requires a different approach. It uses Nanthealth's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Nanthealth Enterprise Value is most likely to decrease significantly in the upcoming years. The preceding year's Enterprise Value was reported at 498.46 Million. The current Tangible Asset Value is estimated to increase to about 49.9 M, while Free Cash Flow is projected to decrease to (28 M).
Nanthealth secures a last-minute Real Value of $1.24 per share. The latest price of the firm is $0.61. Nanthealth is undervalued. Our model forecasts the value of Nanthealth from analyzing the firm fundamentals such as Return On Equity of 1.80 %, current valuation of 304.38 M, and Profit Margin of (93.55) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
  
Nanthealth Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Nanthealth's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Nanthealth Most Recent Valuation Data

EPS Estimate Next Quarter
-0.09
Price Sales
1.12
EBITDA
-40 M
Beta
1.83
Fiscal Year End
December
Industry
Health Information Services
Enterprise Value
315.6 M
Undervalued
Today 0.61
Please note that Nanthealth's price fluctuation is extremely dangerous at this time. Calculation of the real value of Nanthealth is based on 3 months time horizon. Increasing Nanthealth's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Nanthealth is useful when determining the fair value of the Nanthealth stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Nanthealth. Since Nanthealth is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nanthealth Stock. However, Nanthealth's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
1.24
Real Value
6.83
Upside
Estimating the potential upside or downside of Nanthealth helps investors to forecast how Nanthealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nanthealth more accurately as focusing exclusively on Nanthealth's fundamentals will not take into account other important factors:
Earnings
Estimates (2)
LowProjected EPSHigh
-0.4-0.39-0.38
Details
Hype
Prediction
LowEstimated ValueHigh
0.030.616.20
Details
Naive
Forecast
LowNext ValueHigh
0.0111540.566.14
Details
2 Analysts
Consensus
LowTarget PriceHigh
2.503.254.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nanthealth's intrinsic value based on its ongoing forecasts of Nanthealth's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nanthealth's closest peers. When choosing an evaluation method for Nanthealth, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Nanthealth Investments

29.28 Million

Nanthealth Valuation Drivers Correlation

Many accounts on the financial statements of Nanthealth are highly interrelated and sometimes correlated. Consequently, when conducting Nanthealth's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Nanthealth
Click cells to compare fundamentals

Nanthealth Valuation Trend

Knowing Nanthealth's actual value is paramount for traders to make sound investment determinations. Nanthealth's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Nanthealth's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Nanthealth's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Nanthealth Market Cap

Nanthealth is considered to be number one stock in market capitalization category among related companies. Market capitalization of Health Information Services industry is now estimated at about 1.69 Billion. Nanthealth holds roughly 64.67 Million in market capitalization claiming about 4% of equities under Health Information Services industry.
Capitalization  Workforce  Total debt  Revenue  Valuation

Nanthealth Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Nanthealth's current stock value. Our valuation model uses many indicators to compare Nanthealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanthealth competition to find correlations between indicators driving Nanthealth's intrinsic value. More Info.
Nanthealth is considered to be number one stock in price to earning category among related companies. It is considered to be number one stock in price to book category among related companies . Price to Book Value is estimated to decrease to -2.97. Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanthealth by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanthealth's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanthealth's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nanthealth's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nanthealth and how it compares across the competition.

About Nanthealth Valuation

The equity valuation mechanism determines the current worth of Nanthealth on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Nanthealth. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nanthealth based exclusively on its fundamental and basic technical indicators. By analyzing Nanthealth's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Nanthealth's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nanthealth. We calculate exposure to Nanthealth's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nanthealth's related companies.
Fiscal Year End
December
Industry
Health Information Services
Concentration
Health Care Technology
Full Time Employees
326.0
Service Category
Health Care Technology
Employer Id Number
27-3019889
Last ReportedProjected for 2022
Gross Profit50.5 M47.2 M
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Nanthealth operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 326 people.

Nanthealth Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Nanthealth does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio0.86
Revenue Growth1.30%
Enterprise Value To Ebitda-7.99
Enterprise Value To Revenue4.84

Nanthealth Current Valuation Indicators

Valuation refers to the process of determining the present value of Nanthealth and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Nanthealth we look at many different elements of the entity such as Nanthealth's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Nanthealth's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Nanthealth's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nanthealth, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nanthealth's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nanthealth's worth.
Additionally, see Stocks Correlation. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
70.9 M
Quarterly Revenue Growth YOY
0.025
Return On Assets
-0.15
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.